Kerala aims at 100% antibiotic literacy by December

Kerala is working towards keeping its December 2025 deadline for turning into a totally antibiotic-literate State.
By December this year, the State intends to conduct antibiotic awareness activities in all hospitals and local self-government institutions (LSGIs) and ensure that no antibiotics are dispensed anywhere in the State without a proper prescription, Health Minister Veena George said here on Tuesday.
She was releasing a booklet on the awareness activities on antimicrobial resistance (AMR) and proper antibiotic use conducted by the Health department across all districts as part of World AMR Awareness Week, which was observed from November 18 to 24, 2024.
Some 395 LSGIs and 734 hospitals in the State had together conducted 2,852 AMR awareness programmes. About 404 private hospitals, 2,238 educational institutions, and 1,530 pharmacies had joined the AMR awareness initiative
The Antibiotic Literate Kerala campaign will aim at creating general public awareness on the importance of keeping drinking water and food free of antibiotic residues and how antibiotics should be consumed only as directed by a physician.
The campaign will also focus on making the public aware about the significance of disposing of unused or date-expired antibiotic drugs safely, ensuring that they do not pollute waterbodies or are not thrown carelessly into soil. To aid this, an initiative launched by the State Drugs Control department — nPROUD — to ensure the safe disposal of drugs will be scaled up across the State.
Despite the efforts at awareness creation, AMR awareness remains at about 40% in the State, multiple studies have proved. Also, the participation of private health sector institutions in AMR-prevention activities has not come up to the desired level.
The ambitious goal of 100% antibiotic literacy can be achieved only if the State gives renewed attention to private health sector engagement. Thus, this year, all professional medical associations like the Indian Academy of Paediatrics, Association of Physicians of India, and the Indian Medical Association have pledged to focus more on improving private health sector engagement
AMR is a silent pandemic and hence raising awareness and understanding of AMR and promotion of best practices among all One Health stakeholders is important to reduce the emergence and spread of drug-resistant infections.
The general public should thus understand that the rational and judicious use of antibiotics is important to prevent the emergence of antibiotic-resistant strains of pathogens. Antibiotics should be bought and consumed only when the doctor prescribes them and care should be taken that the course of medicine as instructed by the doctor is completed by the patient, the Health department says.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

2 days ago

• Business Standard

Pharma manufacturing tends to cause AMR in communities: Nick Voulvoulis

Changes are required both in manufacturing practices as well as in regulatory oversight, says Voulvoulis Sohini Das Mumbai Listen to This Article Nick Voulvoulis is professor of environmental technology at the Centre for Environmental Policy, Imperial College, London. He has collaborated with Indian institutions for research that uncovered the link between antibiotic manufacturing in the country and the rise of antimicrobial resistance (AMR). Voulvoulis, in an email interview with Sohini Das, explained how low-cost antibiotics pressure manufacturers to spend on costly waste disposal. Edited excerpts: Which AMR research projects are you working on? I led a project called AMRWatch, which was one of five funded projects under the India-UK Tackling AMR in the Environment from Antimicrobial Manufacturing Waste programme funded by the

The Hindu

2 days ago

• The Hindu

SCIINV Biosciences inks pact with UK- based Microbira Ltd

SCIINV Biosciences, a Hyderabad-based biotech startup incubated at ASPIRE BioNEST, University of Hyderabad (UoH), has announced a strategic partnership with Microbira Ltd, a UK-based biotechnology firm on Wednesday. The collaboration aims to develop and deploy next-generation digital diagnostic solutions to strengthen India's fight against antimicrobial resistance (AMR). 'This initiative is a crucial step in curbing inappropriate antibiotic use through timely pathogen detection. Such targeted interventions are fundamental in our fight against drug resistance,' said Prof. Pallu Reddanna, senior professor (retd.), School of Life Sciences. Infectious diseases specialist Ranga Reddy Burri said combating AMR requires affordable, accessible, and reliable diagnostics. CEO of Microbira Ltd, Marianne Ismail, CEO of ASPIRE BioNEST Anil Konda Reddy and SCIINV Biosciences Krishna Burri were also present, said a press release.

Time of India

3 days ago

• Time of India

Advanced pre-symptomatic treatment for spinal muscular atrophy provided in Kerala, first in India

Thiruvananthapuram: For the first time in India, pre-symptomatic treatment to an infant, diagnosed with spinal muscular atrophy (SMA) within days of birth, was provided in Kerala, marking a significant step in rare disease treatment. Tired of too many ads? go ad free now The pre-symptomatic treatment, which was highly effective in the USA and Canada, was successfully conducted in the state. The second child of a woman from Thiruvananthapuram received the expensive drug Risdiplam for free. Health minister Veena George congratulated the entire team for delivering world-class advanced treatment, setting an example for the nation. The inability to identify genetic disorders and their risk factors early often poses a challenge for SMA treatment. However, with pre-symptomatic treatment, medication for SMA can be administered during pregnancy or within days of birth. This approach allows children to achieve 100% normal growth. The woman, also affected by SMA, sought govt assistance to save her unborn child after understanding the risk. George instructed the child health nodal officer to take necessary action. Treatment was then ensured at SAT Hospital, Thiruvananthapuram. A specialised committee assessed each stage of the pregnancy to determine treatment based on the severity of the condition. Genetic counselling and adherence to protocols from similar cases in developed countries were part of the treatment process. "When both parents carry the defective SMA gene, there is a 50% chance that each of their children could inherit the disease. Studies show that in India, there is a possibility of one child being diagnosed with this disease for every 7,000 births," said an official statement. Tired of too many ads? go ad free now To ensure comprehensive care for children with rare diseases, a special scheme was formulated in 2024, marking a first in India. Govt's policy "Diseases may be rare, but care should not be" led to the launch of CARE project. Through this initiative, over 100 children affected by rare diseases, including SMA, receive expensive medications and corrective surgeries for spinal curvature free of cost.